ArticleJournal of functional biomaterials2025
Antibacterial Characteristics of Nanoclay-Infused Cavit Temporary Filling Material: In Vitro Study.
Article in Journal of functional biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Assessment of biofilm resistance, degree of conversion, and mechanical properties of nanomodified 3D-printed orthodontic clear aligner (in-vitro study).BMC oral health · 2026Article
- From Fundamental Biointeractions to Advanced Clinical Therapies in Dentistry Using Biomaterials and Biological Components: An Editorial.Journal of functional biomaterials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
In pediatric endodontic procedures, final crown placement is often delayed, requiring the use of temporary filling materials to seal the access cavity. Given the importance of antibacterial properties in temporary restorations and the known antimicrobial effects of nanoclay particles, this study aimed to evaluate the antibacterial efficacy of a nanoclay-infused temporary dressing against cariogenic and residual intracanal bacteria. A commercial temporary material (CAVISOL, Tehran, Iran) was blended with nanoclay (SOUTHERN, Gonzalez, TX, USA; average size 95 nm), using eugenol as a wetting agent. The antibacterial effects on
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.